feed,title,long_url,short_url
Benzinga,AstraZeneca's $2.4B Fusion Pharmaceuticals' Acquisition Signals Shift In Efforts From Traditional Regimens For More Targeted Cancer Treatments,https://benzinga.com/general/biotech/24/03/37818128/astrazenecas-2-4b-fusion-pharmaceuticals-acquisition-signals-shift-in-efforts-from-traditional-re,https://da.gd/7UnRp
Benzinga,Why Data Analytics Company Spire Global Shares Are Surging Today,https://benzinga.com/markets/equities/24/03/37818120/why-data-analytics-company-spire-global-shares-are-surging-today,https://da.gd/jHv7Cp
